FDA Inspection 1274983 — Royal Biologics, Inc.
The FDA completed an inspection of Royal Biologics, Inc. on June 25, 2025 in Hackensack, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 25, 2025
- Fiscal Year
- 2025
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Hackensack, NJ (United States)